DE69535634D1 - Modulatoren der funktion des fas/ap01 rezeptors - Google Patents

Modulatoren der funktion des fas/ap01 rezeptors

Info

Publication number
DE69535634D1
DE69535634D1 DE69535634T DE69535634T DE69535634D1 DE 69535634 D1 DE69535634 D1 DE 69535634D1 DE 69535634 T DE69535634 T DE 69535634T DE 69535634 T DE69535634 T DE 69535634T DE 69535634 D1 DE69535634 D1 DE 69535634D1
Authority
DE
Germany
Prior art keywords
fas
function
modulators
receptor
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69535634T
Other languages
English (en)
Other versions
DE69535634T2 (de
Inventor
David Wallach
Mark Boldin
Eugene Varfolomeev
Igor Mett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL11200294A external-priority patent/IL112002A0/xx
Priority claimed from IL112692A external-priority patent/IL112692A/en
Priority claimed from IL11461595A external-priority patent/IL114615A0/xx
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Application granted granted Critical
Publication of DE69535634D1 publication Critical patent/DE69535634D1/de
Publication of DE69535634T2 publication Critical patent/DE69535634T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/641—Cysteine endopeptidases (3.4.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • C12N9/6475—Interleukin 1-beta convertase-like enzymes (3.4.22.10; 3.4.22.36; 3.4.22.63)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transmitters (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Radar Systems Or Details Thereof (AREA)
DE69535634T 1994-12-15 1995-12-14 Modulatoren der funktion des fas/ap01 rezeptors Expired - Lifetime DE69535634T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
IL11200294A IL112002A0 (en) 1994-05-11 1994-12-15 Modulatiors of tnf/ngf superfamily receptors, their preparation and use
IL11200294 1994-12-15
IL112692A IL112692A (en) 1995-02-19 1995-02-19 ANTIBODIES TO PROTEIN WHICH BINDS TO Fas-R
IL11269295 1995-02-19
IL11461595 1995-07-16
IL11461595A IL114615A0 (en) 1995-07-16 1995-07-16 Modulators of the function of fas receptors and other proteins
PCT/US1995/016542 WO1996018641A1 (en) 1994-12-15 1995-12-14 Modulators of the function of fas/apo1 receptors

Publications (2)

Publication Number Publication Date
DE69535634D1 true DE69535634D1 (de) 2007-12-13
DE69535634T2 DE69535634T2 (de) 2008-08-28

Family

ID=27271687

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69535634T Expired - Lifetime DE69535634T2 (de) 1994-12-15 1995-12-14 Modulatoren der funktion des fas/ap01 rezeptors

Country Status (18)

Country Link
EP (1) EP0871645B1 (de)
JP (1) JP3787355B2 (de)
KR (1) KR100536394B1 (de)
CN (1) CN1105725C (de)
AT (1) ATE377073T1 (de)
AU (1) AU706401B2 (de)
CA (1) CA2207815C (de)
CY (1) CY2586B2 (de)
DE (1) DE69535634T2 (de)
DK (1) DK0871645T3 (de)
ES (1) ES2292172T3 (de)
FI (1) FI121273B (de)
HK (1) HK1007248A1 (de)
MX (1) MX9704501A (de)
NO (1) NO324725B1 (de)
PT (1) PT871645E (de)
UA (1) UA58489C2 (de)
WO (1) WO1996018641A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114615A0 (en) * 1995-07-16 1995-11-27 Yeda Res & Dev Modulators of the function of fas receptors and other proteins
US6015665A (en) * 1995-02-13 2000-01-18 The Regents Of The University Of Michigan Method and composition for regulating apoptosis
US6060238A (en) * 1995-02-13 2000-05-09 The Regents Of The University Of Michigan Method and composition for regulating apoptosis
US7097972B1 (en) 1995-02-13 2006-08-29 Regents Of The University Of Michigan Method and composition for regulating apoptosis
AU755662B2 (en) * 1995-02-22 2002-12-19 Yeda Research And Development Co. Ltd. Modulators of regulatory proteins
ES2242195T3 (es) * 1995-02-22 2005-11-01 YEDA RESEARCH & DEVELOPMENT COMPANY, LTD. Moduladores de proteinas reguladoras.
US6747138B1 (en) 1995-04-03 2004-06-08 Regents Of The University Of Michigan Methods and compositions for regulating Fas-associated apoptosis
US7807783B1 (en) * 1995-04-03 2010-10-05 The Regents Of The University Of Michigan Methods and compositions for regulating FAS-associated apoptosis
US6399327B1 (en) 1995-07-16 2002-06-04 Yeda Research And Development Co. Ltd. Modulators of the function of FAS receptors and other proteins
US6911526B2 (en) * 1996-07-22 2005-06-28 The Trustees Of Columbia University In The City Of New York Compounds that inhibit the interaction between signal-transducing proteins and the GLGF (PDZ/DHR) domain and uses thereof
EP0842665A3 (de) * 1996-11-14 2002-12-18 Smithkline Beecham Corporation Interleukin-1-beta-konvertierendes-Enzym-ähnliche Apoptosisproteasen und ihre Agonisten
US5969102A (en) * 1997-03-03 1999-10-19 St. Jude Children's Research Hospital Lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof
WO1998049297A1 (en) * 1997-04-25 1998-11-05 American Home Products Corporation Neuronal mort1 isoforms
AU7988698A (en) * 1997-06-26 1999-01-19 Chiron Corporation Human fadd-interacting protein (fip)
US7833529B1 (en) 1999-01-07 2010-11-16 Zymogenetics, Inc. Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor
US6015712A (en) * 1999-07-19 2000-01-18 Isis Pharmaceuticals Inc. Antisense modulation of FADD expression
KR20040030628A (ko) 2001-05-24 2004-04-09 지모제넥틱스, 인코포레이티드 Ｔａｃｉ-면역글로불린 융합 단백질
US6743630B2 (en) 2002-03-06 2004-06-01 The Trustees Of Columbia University In The City Of New York Method of preparing a protein array based on biochemical protein-protein interaction
EP1922079A2 (de) 2005-08-09 2008-05-21 ZymoGenetics, Inc. Verfahren zur behandlung und prävention abnormaler zellproliferation mittels taci-fusionsmolekülen
JP2009507777A (ja) 2005-08-09 2009-02-26 ザイモジェネティクス，インコーポレイティド ＴＡＣＩ−Ｉｇ融合分子を用いたＢ細胞性腫瘍の処置方法
US8784812B2 (en) 2006-05-15 2014-07-22 Zymogenetics, Inc. Methods for treating autoimmune diseases using a TACI-Ig fusion molecule

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO178777C (no) * 1994-05-09 1996-05-29 Kvaerner Eng Varmeveksler
US7807783B1 (en) * 1995-04-03 2010-10-05 The Regents Of The University Of Michigan Methods and compositions for regulating FAS-associated apoptosis
US5674734A (en) * 1995-05-18 1997-10-07 President And Fellows Of Harvard College Cell death protein

Also Published As

Publication number Publication date
FI972457A (fi) 1997-06-10
NO972716L (no) 1997-07-11
ATE377073T1 (de) 2007-11-15
CA2207815A1 (en) 1996-06-20
CA2207815C (en) 2011-03-29
HK1007248A1 (en) 1999-04-09
CY2586B2 (en) 2009-11-04
EP0871645A1 (de) 1998-10-21
JPH10510712A (ja) 1998-10-20
NO972716D0 (no) 1997-06-12
FI121273B (fi) 2010-09-15
CN1169729A (zh) 1998-01-07
NO324725B1 (no) 2007-12-03
MX9704501A (es) 1997-10-31
KR100536394B1 (ko) 2006-04-21
EP0871645B1 (de) 2007-10-31
FI972457A0 (fi) 1997-06-10
CN1105725C (zh) 2003-04-16
AU4602296A (en) 1996-07-03
WO1996018641A1 (en) 1996-06-20
PT871645E (pt) 2007-11-14
DE69535634T2 (de) 2008-08-28
JP3787355B2 (ja) 2006-06-21
DK0871645T3 (da) 2007-12-03
EP0871645A4 (de) 1999-11-24
UA58489C2 (uk) 2003-08-15
AU706401B2 (en) 1999-06-17
ES2292172T3 (es) 2008-03-01

Similar Documents

Publication Publication Date Title
CY2586B2 (en) Modulators of the function of FAS/APO1 receptors
MY136336A (en) Modified vitamin k-dependent polypeptides
DE69632827D1 (de) Materialen und methoden im zusammenhang mit bindung und präsentation von substanzen auf zelloberflächen
AU2894289A (en) Domain-modified constant region antibodies
GEP20022619B (en) Novel Cell Systems Having Specific Interaction of Peptide Binding Pairs
AU6402694A (en) Methods and materials relating to the functional domains of dna binding proteins
AR014891A1 (es) Genes aislados de proteinas de membranas de mamiferos; reactivos relacionados
EP1798286A3 (de) Membranproteine aus Säugetierzellen und verwandte Reagentien
ES8706827A1 (es) Procedimiento para preparar polipeptidos.
ES2194012T3 (es) Epitopo p1a1 y p1a2 de la gpiii a de plaquetas, su preparacion y uso.
ES8802538A1 (es) Un metodo de producir una proteina capaz de modular la actividad fisiologica de celulas que tienen un receptor de diazepam
AU7423391A (en) Dna constructs for the expression of proteins in the mammary gland of transgenetic mammals
IL133129A0 (en) Prenylcysteine carboxyl methyltransferase dna encoding same and a method of screening for inhibistors thereof
AU1908395A (en) Antibodies to mammalian natural killer antigens and uses
AU6997794A (en) Process for screening substances having a modulating effect on an interleukine-5-receptor-dependent cellular signal transmission path
DE69430846T2 (de) Für natürliche killerzellen spezifische antigene und sie identifizierende antikörper
BG104769A (en) Modulators of the function of receptors of the tnf/ngf receptor family and other proteins
AU1695595A (en) Mammalian thymokine genes
WO1999047709A3 (en) Methods for identifying anti-cancer agents
DK0870015T3 (da) Xylanaser, gener, der koder for disse, samt anvendelser deraf
AU4365196A (en) Purified genes encoding mammalian cell surface antigens; proteins and antibodies
WO2000034335A3 (en) 'death domain' containing receptors
WO1999027094A3 (en) HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
AU9790398A (en) Mrit family of cell death proteins, nucleic acids encoding same, and methods of use
AU7718294A (en) Mammalian stromal cell proteins and dna sequences coding therefor

Legal Events

Date Code Title Description
8364 No opposition during term of opposition